Aligos Therapeutics Ownership | Who Owns Aligos Therapeutics?

Overview Forecast RevenueFinancials Chart

Aligos Therapeutics Ownership Summary

Aligos Therapeutics is owned by 30.28% institutional investors, 20.07% insiders, and 49.65% retail investors. Bank of america corp /de/ is the largest institutional shareholder, holding 0.52% of ALGS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.84% of its assets in Aligos Therapeutics shares.

ALGS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aligos Therapeutics	30.28%	20.07%	49.65%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bank of america corp /de/	816.03K	0.52%	$285.61K
Geode capital management	405.69K	0.26%	$142.02K
Blackrock	227.41K	0.15%	$79.59K
State street	107.12K	0.07%	$37.49K
Charles schwab investment management	31.38K	0.02%	$10.98K
Millennium management	29.88K	0.02%	$10.46K
Two sigma investments, lp	18.71K	0.01%	$6.55K
Virtu financial	12.31K	0.01%	$4.00K
Morgan stanley	3.30K	0.00%	$1.16K
Nelson, van denburg & campbell wealth management group	80.00	0.00%	$3.19K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Virtu financial	12.31K	0.00%	$4.00K
Nelson, van denburg & campbell wealth management group	80.00	0.00%	$3.19K
Prudential financial	-	-	-
Renaissance	-	-	-
Zrc wealth management	-	-	-
Ecor1 capital	-	-	-
Opaleye management	-	-	-
Blackrock	227.41K	-	$79.59K
Harbourvest partners	-	-	-
Silverarc capital management	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Geode capital management	405.69K	-	32.64K
Virtu financial	12.31K	0.00%	12.31K
State street	107.12K	-	9.70K
Citadel advisors	300.00	-	100.00
Two sigma investments, lp	18.71K	-	82.00

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-7.26M
Ecor1 capital	-	-	-6.39M
Deep track capital, lp	-	-	-6.10M
Adage capital partners gp	-	-	-5.00M
Vivo capital	-	-	-3.55M

New Positions

Holder	Shares	% Assets	Change	Value
Virtu financial	12.31K	0.00%	12.31K	$4.00K
Nelson, van denburg & campbell wealth management group	80.00	0.00%	80.00	$3.19K

Sold Out

Holder	Change
Qube research	-2.00
Zrc wealth management	-100.00
Wells fargo & company/mn	-298.00
Simplex trading	-1.10K
Advisor group	-5.50K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	48	-5.88%	47,289,231	2.33%	30	0.59%	17	-29.17%	13	160.00%
Mar 31, 2024	51	27.50%	46,213,782	1.91%	71	0.66%	24	41.18%	5	-28.57%
Dec 31, 2023	40	11.11%	45,349,618	76.22%	104	2.94%	17	240.00%	7	-30.00%
Sep 30, 2023	36	-14.29%	25,734,205	-2.11%	59	1.59%	5	-37.50%	10	-23.08%
Jun 30, 2023	42	-10.64%	26,288,771	-3.87%	61	1.51%	8	-63.64%	13	18.18%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	66.08K	1.84%	13.28K
Vanguard Institutional Extnd Mkt Idx Tr	29.61K	0.83%	-
Fidelity Extended Market Index	12.31K	0.34%	-81.00
Schwab US Small-Cap ETF™	11.43K	0.32%	-2.15K
Extended Equity Market Fund K	5.31K	0.15%	4.17K
Fidelity Total Market Index	4.36K	0.12%	-
Fidelity Series Total Market Index	2.94K	0.08%	-212.00
NT Ext Equity Mkt Idx Fd - L	2.87K	0.08%	1.43K
NT Ext Equity Mkt Idx Fd - NL	2.15K	0.06%	-
Spartan Extended Market Index Pool E	2.00K	0.06%	81.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 25, 2023	Nuechterlein Carole		Buy	$6.00M
Oct 25, 2023	Nuechterlein Carole		Buy	$3.00M
Oct 20, 2020	Novo Holdings A/S	-	Buy	$3.00M
Oct 20, 2020	Woiwode Thomas	-	Buy	$3.00M
Oct 20, 2020	Vivo Capital VIII, LLC	-	Buy	$7.25M

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	2	-

ALGS Ownership FAQ

Who Owns Aligos Therapeutics?

Aligos Therapeutics shareholders are primarily institutional investors at 30.28%, followed by 20.07% insiders and 49.65% retail investors. The average institutional ownership in Aligos Therapeutics's industry, Biotech Stocks , is 109.70%, which Aligos Therapeutics falls below.

Who owns the most shares of Aligos Therapeutics?

Aligos Therapeutics’s largest shareholders are Bank of america corp /de/ (816.03K shares, 0.52%), Geode capital management (405.69K shares, 0.26%), and Blackrock (227.41K shares, 0.15%). Together, they hold 0.93% of Aligos Therapeutics’s total shares outstanding.

Does Blackrock own Aligos Therapeutics?

Yes, BlackRock owns 0.15% of Aligos Therapeutics, totaling 227.41K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 79.59K$. In the last quarter, BlackRock decreased its holdings by -76.349K shares, a -25.14% change.

Who is Aligos Therapeutics’s biggest shareholder by percentage of total assets invested?

Virtu financial is Aligos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 12.31K Aligos Therapeutics shares, valued at 4K$.

Who is the top mutual fund holder of Aligos Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aligos Therapeutics shares, with 1.84% of its total shares outstanding invested in 66.08K Aligos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools